This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Jan 15;372(3):275-7.

doi: 10.1056/NEJMe1414112. Epub 2014 Nov 21.

A new era for the treatment of hyperkalemia?

Julie R Ingelfinger

PMID: 25415806
DOI: 10.1056/NEJMe1414112

Editorial

A new era for the treatment of hyperkalemia?

Julie R Ingelfinger. N Engl J Med. 2015.

. 2015 Jan 15;372(3):275-7.

doi: 10.1056/NEJMe1414112. Epub 2014 Nov 21.

Author

Julie R Ingelfinger

PMID: 25415806
DOI: 10.1056/NEJMe1414112

No abstract available

PubMed Disclaimer

Comment in

New agents for hyperkalemia.
Synhavsky A. Synhavsky A. N Engl J Med. 2015 Apr 16;372(16):1570. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25875266 No abstract available.

Comment on

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, Pitt B; OPAL-HK Investigators. Weir MR, et al. N Engl J Med. 2015 Jan 15;372(3):211-21. doi: 10.1056/NEJMoa1410853. Epub 2014 Nov 21. N Engl J Med. 2015. PMID: 25415805 Clinical Trial.
Sodium zirconium cyclosilicate in hyperkalemia.
Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G, Qunibi W, Pergola P, Singh B. Packham DK, et al. N Engl J Med. 2015 Jan 15;372(3):222-31. doi: 10.1056/NEJMoa1411487. Epub 2014 Nov 21. N Engl J Med. 2015. PMID: 25415807 Clinical Trial.

Similar articles

New agents for hyperkalemia.
Yuan CM, Little DJ, Nee R. Yuan CM, et al. N Engl J Med. 2015 Apr 16;372(16):1570. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25875267 No abstract available.
New agents for hyperkalemia.
Synhavsky A. Synhavsky A. N Engl J Med. 2015 Apr 16;372(16):1570. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25875266 No abstract available.
New agents for hyperkalemia.
Weir MR, Bakris GL, Pitt B. Weir MR, et al. N Engl J Med. 2015 Apr 16;372(16):1570-1. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25875263 No abstract available.
Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis.
Palmer BF. Palmer BF. Mayo Clin Proc. 2020 Feb;95(2):339-354. doi: 10.1016/j.mayocp.2019.05.019. Epub 2019 Oct 23. Mayo Clin Proc. 2020. PMID: 31668450 Review.
Potassium binding for conservative and preservative management of chronic kidney disease.
Clegg DJ, Palmer BF. Clegg DJ, et al. Curr Opin Nephrol Hypertens. 2020 Jan;29(1):29-38. doi: 10.1097/MNH.0000000000000564. Curr Opin Nephrol Hypertens. 2020. PMID: 31714287 Review.

See all similar articles

Cited by

Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials.
Carvalho PEP, Veiga TMA, Lacerda H, Tofanelli MR, Gewehr DM, Nunes MCP, Simões E Silva AC. Carvalho PEP, et al. Clin Res Cardiol. 2023 Jul;112(7):991-1002. doi: 10.1007/s00392-023-02215-2. Epub 2023 May 4. Clin Res Cardiol. 2023. PMID: 37140823
Chinese Clinical Practice Guideline for the Management of "CKD-PeriDialysis"-the Periods Prior to and in the Early-Stage of Initial Dialysis.
Chinese Experts Group of the Guideline for the Management of ‘CKD-PeriDialysis’; Chinese Non-government Medical Institutions Association. Chinese Experts Group of the Guideline for the Management of ‘CKD-PeriDialysis’, et al. Kidney Int Rep. 2022 Dec 12;7(12 Suppl):S531-S558. doi: 10.1016/j.ekir.2022.10.001. eCollection 2022 Dec. Kidney Int Rep. 2022. PMID: 36567827 Free PMC article.
Treatment of Mild Hyperkalemia in Hospitalized Patients: An Unnecessary Practice?
Freeze TA, Skerry L, Kervin E, Nunn R, Woodland J, Hanson N, MacKinnon M. Freeze TA, et al. Can J Hosp Pharm. 2021 Summer;74(3):269-276. doi: 10.4212/cjhp.v74i3.3154. Epub 2021 Jul 1. Can J Hosp Pharm. 2021. PMID: 34248167 Free PMC article.
Selective potassium uptake via biocompatible zeolite-polymer hybrid microbeads as promising binders for hyperkalemia.
Wang Z, Sun W, Wei Z, Bao J, Song X, Li Y, Ji H, Zhang J, He C, Su B, Zhao W, Zhao C. Wang Z, et al. Bioact Mater. 2020 Sep 12;6(2):543-558. doi: 10.1016/j.bioactmat.2020.08.032. eCollection 2021 Feb. Bioact Mater. 2020. PMID: 32995679 Free PMC article.
Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.
Adelborg K, Nicolaisen SK, Hasvold P, Palaka E, Pedersen L, Thomsen RW. Adelborg K, et al. PLoS One. 2019 Jun 21;14(6):e0218739. doi: 10.1371/journal.pone.0218739. eCollection 2019. PLoS One. 2019. PMID: 31226134 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information